Skip to main content
Premium Trial:

Request an Annual Quote

Curetis Receives Malaysia, Thailand Regulatory Approvals

NEW YORK (GenomeWeb) – Curetis announced today its distribution partner, Acumen Research Laboratories, has received its first approvals to market certain of its products in Malaysia and Thailand. The approvals are expected to further the commercial rollout of Curetis' Unyvero automated molecular diagnostic platform.

Specifically, Singapore-based Acumen has won approval to market the Unyvero BCU Blood Culture Application Cartridge in Thailand and the Curetis Hospitalized Pneumonia Application Cartridge in both Malaysia and Thailand. Both cartridges run on the Unyvero system.

With the new approvals, the pneumonia panel is now fully registered as an IVD medical device in Singapore, Malaysia, and Thailand, Curetis noted in a statement.

"The further regulatory approval of several Unyvero Application Cartridges in Asian markets beyond the Singapore bridgehead have the potential to contribute to further growth of our Unyvero business in the entire [Association of Southeast Asian Nations] region," Curetis CEO Oliver Schacht said in a statement.

The firm is now preparing for a significant commercial expansion of its Unyvero portfolio in Asia in the coming years, Schacht said, with expectation of a near-term regulatory submission to the Chinese National Medical Product Administration for the Unyvero HPN Application by its partner Beijing Clear Biotech, as well as further clinical studies supporting market access in China and beyond.

Acumen and Curetis intend to submit additional Unyvero Application Cartridges for regulatory approval in the ASEAN markets to further the commercial roll-out of Unyvero in the region, the firm said.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.